1010 related articles for article (PubMed ID: 34817202)
1. Analysis of Glycosylation and Disulfide Bonding of Wild-Type SARS-CoV-2 Spike Glycoprotein.
Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski JG
J Virol; 2022 Feb; 96(3):e0162621. PubMed ID: 34817202
[TBL] [Abstract][Full Text] [Related]
2. Analysis of glycosylation and disulfide bonding of wild-type SARS-CoV-2 spike glycoprotein.
Zhang S; Go EP; Ding H; Anang S; Kappes JC; Desaire H; Sodroski J
bioRxiv; 2021 Apr; ():. PubMed ID: 33821278
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
Elife; 2020 Oct; 9():. PubMed ID: 33103998
[TBL] [Abstract][Full Text] [Related]
4. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity.
Zhang F; Schmidt F; Muecksch F; Wang Z; Gazumyan A; Nussenzweig MC; Gaebler C; Caskey M; Hatziioannou T; Bieniasz PD
mBio; 2024 Feb; 15(2):e0167223. PubMed ID: 38193662
[TBL] [Abstract][Full Text] [Related]
6. A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.
Mondal T; Shivange G; Habieb A; Tushir-Singh J
Microbiol Spectr; 2022 Feb; 10(1):e0236421. PubMed ID: 35138160
[TBL] [Abstract][Full Text] [Related]
7. Site specific N- and O-glycosylation mapping of the spike proteins of SARS-CoV-2 variants of concern.
Shajahan A; Pepi LE; Kumar B; Murray NB; Azadi P
Sci Rep; 2023 Jun; 13(1):10053. PubMed ID: 37344512
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.
Rowland R; Brandariz-Nuñez A
Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876
[TBL] [Abstract][Full Text] [Related]
9. N-glycosylation of the SARS-CoV-2 spike protein at Asn331 and Asn343 is involved in spike-ACE2 binding, virus entry, and regulation of IL-6.
Das T; Luo S; Tang H; Fang J; Mao Y; Yen HH; Dash S; Shajahan A; Pepi L; Huang S; Jones VS; Xie S; Huang GF; Lu J; Anderson B; Zhang B; Azadi P; Huang RP
Microbiol Immunol; 2024 May; 68(5):165-178. PubMed ID: 38444370
[TBL] [Abstract][Full Text] [Related]
10. Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro.
Huang HC; Lai YJ; Liao CC; Yang WF; Huang KB; Lee IJ; Chou WC; Wang SH; Wang LH; Hsu JM; Sun CP; Kuo CT; Wang J; Hsiao TC; Yang PJ; Lee TA; Huang W; Li FA; Shen CY; Lin YL; Tao MH; Li CW
EBioMedicine; 2021 Dec; 74():103712. PubMed ID: 34839261
[TBL] [Abstract][Full Text] [Related]
11. Glycosylation and Serological Reactivity of an Expression-enhanced SARS-CoV-2 Viral Spike Mimetic.
Chawla H; Jossi SE; Faustini SE; Samsudin F; Allen JD; Watanabe Y; Newby ML; Marcial-Juárez E; Lamerton RE; McLellan JS; Bond PJ; Richter AG; Cunningham AF; Crispin M
J Mol Biol; 2022 Jan; 434(2):167332. PubMed ID: 34717971
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.
Li T; Zheng Q; Yu H; Wu D; Xue W; Xiong H; Huang X; Nie M; Yue M; Rong R; Zhang S; Zhang Y; Wu Y; Wang S; Zha Z; Chen T; Deng T; Wang Y; Zhang T; Chen Y; Yuan Q; Zhao Q; Zhang J; Gu Y; Li S; Xia N
Emerg Microbes Infect; 2020 Dec; 9(1):2076-2090. PubMed ID: 32897177
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation of SARS-CoV-2: structural and functional insights.
Shajahan A; Pepi LE; Rouhani DS; Heiss C; Azadi P
Anal Bioanal Chem; 2021 Dec; 413(29):7179-7193. PubMed ID: 34235568
[TBL] [Abstract][Full Text] [Related]
14. A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera.
Seephetdee C; Bhukhai K; Buasri N; Leelukkanaveera P; Lerdwattanasombat P; Manopwisedjaroen S; Phueakphud N; Kuhaudomlarp S; Olmedillas E; Saphire EO; Thitithanyanont A; Hongeng S; Wongtrakoongate P
Antiviral Res; 2022 Aug; 204():105370. PubMed ID: 35772601
[TBL] [Abstract][Full Text] [Related]
15. N-glycosylation profiles of the SARS-CoV-2 spike D614G mutant and its ancestral protein characterized by advanced mass spectrometry.
Wang D; Zhou B; Keppel TR; Solano M; Baudys J; Goldstein J; Finn MG; Fan X; Chapman AP; Bundy JL; Woolfitt AR; Osman SH; Pirkle JL; Wentworth DE; Barr JR
Sci Rep; 2021 Dec; 11(1):23561. PubMed ID: 34876606
[TBL] [Abstract][Full Text] [Related]
16. The Importance of Glycosylation in COVID-19 Infection.
Petrović T; Lauc G; Trbojević-Akmačić I
Adv Exp Med Biol; 2021; 1325():239-264. PubMed ID: 34495539
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the avian coronavirus spike protein reveals heterogeneity in the glycans present.
Stevenson-Leggett P; Armstrong S; Keep S; Britton P; Bickerton E
J Gen Virol; 2021 Aug; 102(8):. PubMed ID: 34424155
[TBL] [Abstract][Full Text] [Related]
18. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines.
Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287
[TBL] [Abstract][Full Text] [Related]
19. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Walls AC; Park YJ; Tortorici MA; Wall A; McGuire AT; Veesler D
Cell; 2020 Apr; 181(2):281-292.e6. PubMed ID: 32155444
[TBL] [Abstract][Full Text] [Related]
20. The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections.
Musarrat F; Chouljenko V; Dahal A; Nabi R; Chouljenko T; Jois SD; Kousoulas KG
J Med Virol; 2020 Oct; 92(10):2087-2095. PubMed ID: 32374457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
